Special Issue "Multidisciplinary and Personalized Approach for Post-COVID-19 Syndrome"
Deadline for manuscript submissions: 15 November 2023 | Viewed by 1919
Interests: public health; epidemiology; SARS-COV2 infection; pneumology; COVID-19
In the current context, an increasingly clear outline of the impact of COVID-19 (coronavirus disease 2019) is being elucidated, alongside a new category of patients, namely, post-COVID-19 patients, a condition defined at more than 12 weeks after the acute viral episode by the persistence of clinical, imagistic and lung function changes (however, other unrevealed long-term health consequences may yet arise). The data that have become available after SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) was declared a global pandemic have shown that many of these patients return to the hospital with multiple symptoms and dysfunctions more than 6–12 months after the initial diagnosis. The most frequent complications that occur, both in the acute phase and at distance from the acute viral episode, include cardiovascular (myocarditis, arrhythmias), respiratory (pulmonary fibrosis, pulmonary arterial hypertension), metabolic (hyperglycaemia, dyslipidemia), musculoskeletal (reactive arthritis), and psychiatric (depression, post-traumatic stress syndrome) problems. With the multitude of ongoing scientific data and evidence, as well as frequent emerging controversies, constant updates are required in the field in order to characterize this exceptional global health situation. This Special Issue of the Journal of Personalized Medicine wishes to emphasize the importance of carefully following the evolution of patients with post-COVID-19 syndrome in order to be able to foresee and identify all potential complications and minimize long-term effects. In addition, considering the multisystemic impairment following COVID-19, patient follow-up will require a multidisciplinary approach, integrating pulmonology, pulmonary rehabilitation, cardiology, neurological, nephrological, and psychiatric consultations, perhaps with other specialists on a case-to-case basis, with the main objective being to ensure the best care and anticipate the appearance of long-term sequelae in order to develop personalized strategies to optimize the management of patients with post-COVID-19 syndrome.
Prof. Dr. Antigona Carmen Trofor
Prof. Dr. Roxana Maria Nemes
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- long-term effects
- multisystemic impairment
- chronic complications